DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
de Boer SM, Powell ME, Mileshkin L. et al.
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol 2018;
19: 295-309
doi:10.1016/S1470-2045(18)30079-2
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.